From the Department of Nuclear Medicine, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
Clin Nucl Med. 2020 Jul;45(7):561-562. doi: 10.1097/RLU.0000000000003081.
We present a 78-year-old man with suspicion of prostate cancer due to a PSA of 200 ng/mL, who underwent F-PSMA-1007 (prostate specific membrane antigen) PET/CT for primary staging. Besides heterogeneous uptake to the prostate, an increased PSMA uptake in the cecum was observed, located in the thickened cecal wall with suspicion of a secondary malignancy. Colonoscopic biopsy followed by hemicolectomy confirmed the diagnosis of colon adenocarcinoma. This case demonstrates the importance of bioptic workup of suspicious findings on PSMA PET/CT, which are unlikely to be related to prostate cancer as PSMA ligand uptake is not exclusively prostate cancer specific.
我们报告了一例 78 岁男性,因 PSA 为 200ng/mL 而怀疑患有前列腺癌,进行 F-PSMA-1007(前列腺特异性膜抗原)PET/CT 进行原发分期。除了前列腺的不均匀摄取外,还观察到回肠的 PSMA 摄取增加,位于回肠壁增厚处,怀疑为继发性恶性肿瘤。结肠镜检查活检和半结肠切除术证实了结肠腺癌的诊断。该病例表明了对 PSMA PET/CT 上可疑发现进行活检的重要性,这些发现不太可能与前列腺癌有关,因为 PSMA 配体摄取并非专门针对前列腺癌。